Literature DB >> 14752842

Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores.

Francis Y Yao1, Sammy Saab, Nathan M Bass, Ryutaro Hirose, David Ly, Norah Terrault, Ann A Lazar, Peter Bacchetti, Nancy L Ascher, John P Roberts.   

Abstract

The current policy for determining priority for organ allocation is based on the model for end stage liver disease (MELD). We hypothesize that severity of graft dysfunction assessed by either the MELD score or the Child-Turcotte-Pugh (CTP) score correlates with mortality after liver retransplantation (re-OLT). To test this hypothesis, we analyzed the outcome of 40 consecutive patients who received re-OLT more than 90 days after primary orthotopic liver transplantation (OLT). The Kaplan-Meier 1-year and 5-year survival rates after re-OLT were 69% and 62%, respectively. The area under the curve (AUC) values generated by the receiver operating characteristics (ROC) curves were 0.82 (CI 0.70-0.94) and 0.68 (CI 0.49-0.86), respectively (P =.11), for the CTP and MELD models in predicting 1-year mortality after re-OLT. The 1-year and 5-year survival rates for patients with CTP scores less than 10 were 100% versus 50% and 40%, respectively, for CTP scores of at least 10 (P =.0006). Patients with MELD scores less than or equal to 25 had 1-year and 5-year survival rates of 89% and 79%, respectively, versus 53% and 47%, respectively, for MELD scores greater than 25 (P =.038). Other mortality predictors include hepatic encephalopathy, intensive care unit (ICU) stay, recurrent hepatitis C virus (HCV) infection, and creatinine level of 2 mg/dL or higher. Analysis of an independent cohort of 49 patients showed a trend for a correlation between CTP and MELD scores with 1-year mortality, with AUC of 0.59 and 0.57, in respective ROC curves. In conclusion, our results suggest that severity of graft failure based on CTP and MELD scores may be associated with worse outcome after re-OLT and provide a cautionary note for the "sickest first" policy of organ allocation.

Entities:  

Mesh:

Year:  2004        PMID: 14752842     DOI: 10.1002/hep.20005

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  20 in total

1.  Hepatocellular carcinoma biology predicts survival outcome after liver transplantation in the USA.

Authors:  Mohamed Abd El-Fattah
Journal:  Indian J Gastroenterol       Date:  2017-02-14

2.  Liver retransplantation in adults: a single-centre, 25-year experience.

Authors:  Ravi Marudanayagam; Vivekanandan Shanmugam; Bynvant Sandhu; Bridget K Gunson; Darius F Mirza; David Mayer; John Buckels; Simon R Bramhall
Journal:  HPB (Oxford)       Date:  2010-04       Impact factor: 3.647

3.  Association of preoperative parameters with postoperative mortality and long-term survival after liver transplantation.

Authors:  Dionisios Vrochides; Mazzen Hassanain; Jeffrey Barkun; Jean Tchervenkov; Steven Paraskevas; Prosanto Chaudhury; Marcelo Cantarovich; Marc Deschenes; Phil Wong; Peter Ghali; Gabriel Chan; Peter Metrakos
Journal:  Can J Surg       Date:  2011-04       Impact factor: 2.089

4.  Liver transplantation for alcohol-related cirrhosis: a single centre long-term clinical and histological follow-up.

Authors:  M Schmeding; C Heidenhain; R Neuhaus; P Neuhaus; U P Neumann
Journal:  Dig Dis Sci       Date:  2010-05-25       Impact factor: 3.199

5.  Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.

Authors:  Jacqueline B Henson; Yuval A Patel; Lindsay Y King; Jiayin Zheng; Shein-Chung Chow; Andrew J Muir
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

6.  Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.

Authors:  Tomohide Hori; Toshimi Kaido; Fumitaka Oike; Yasuhiro Ogura; Kohei Ogawa; Yukihide Yonekawa; Koichiro Hata; Yoshiya Kawaguchi; Mikiko Ueda; Akira Mori; Hajime Segawa; Kimiko Yurugi; Yasutsugu Takada; Hiroto Egawa; Atsushi Yoshizawa; Takuma Kato; Kanako Saito; Linan Wang; Mie Torii; Feng Chen; Ann-Marie T Baine; Lindsay B Gardner; Shinji Uemoto
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

Review 7.  Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.

Authors:  Jérôme Dumortier; Olivier Boillot; Jean-Yves Scoazec
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

8.  Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.

Authors:  Alice Tung Wan Song; Rodolphe Sobesky; Carmen Vinaixa; Jérôme Dumortier; Sylvie Radenne; François Durand; Yvon Calmus; Géraldine Rousseau; Marianne Latournerie; Cyrille Feray; Valérie Delvart; Bruno Roche; Stéphanie Haim-Boukobza; Anne-Marie Roque-Afonso; Denis Castaing; Edson Abdala; Luiz Augusto Carneiro D'Albuquerque; Jean-Charles Duclos-Vallée; Marina Berenguer; Didier Samuel
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

Review 9.  Management of hepatitis C infection after liver transplantation.

Authors:  Mazen Alsatie; Naga Chalasani; Paul Y Kwo
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Liver retransplantation in adults: the largest multicenter Italian study.

Authors:  Umberto Maggi; Enzo Andorno; Giorgio Rossi; Luciano De Carlis; Umberto Cillo; Fabrizio Bresadola; Vincenzo Mazzaferro; Andrea Risaliti; Paolo Bertoli; Dario Consonni; Francesco Barretta; Tullia De Feo; Mario Scalamogna
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.